US FDA approves Johnson & Johnson's device for heart condition
The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
MarketWatch5d
Johnson & Johnson stock rises Tuesday, still underperforms market
Shares of Johnson & Johnson JNJ inched 0.07% higher to $158.35 Tuesday, on what proved to be an all-around great trading ...
Johnson & Johnson Seeks Approval Of Darzalex Faspro In US, Darzalex In EU For Myeloma Treatment
(RTTNews) - Johnson & Johnson (JNJ), Friday announced the submission of regulatory applications for Darzalex Faspro to the U.S. Food and Drug Administration, and Darzalex to the European Medicines ...
Johnson & Johnson price target raised to $162 from $156 at Guggenheim
Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm ...